Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin …
CA Bousman, JM Stevenson… - Clinical …, 2023 - Wiley Online Library
Serotonin reuptake inhibitor antidepressants, including selective serotonin reuptake
inhibitors (SSRIs; ie, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and …
inhibitors (SSRIs; ie, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and …
Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017
C Hiemke, N Bergemann, HW Clement… - …, 2018 - thieme-connect.com
Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug
concentrations in blood to optimize pharmacotherapy. It considers the interindividual …
concentrations in blood to optimize pharmacotherapy. It considers the interindividual …
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid… - American Journal of …, 2017 - Am Psychiatric Assoc
Objective: Research and clinical translation in schizophrenia is limited by inconsistent
definitions of treatment resistance and response. To address this issue, the authors …
definitions of treatment resistance and response. To address this issue, the authors …
[HTML][HTML] Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants …
Abstract CYP2D6 and CYP2C19 polymorphisms affect the exposure, efficacy and safety of
tricyclic antidepressants (TCAs), with some drugs being affected by CYP2D6 only (eg …
tricyclic antidepressants (TCAs), with some drugs being affected by CYP2D6 only (eg …
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake …
Selective serotonin reuptake inhibitors (SSRIs) are primary treatment options for major
depressive and anxiety disorders. CYP2D6 and CYP2C19 polymorphisms can influence the …
depressive and anxiety disorders. CYP2D6 and CYP2C19 polymorphisms can influence the …
Nutraceuticals in neurological disorders
Neurological diseases are one of the major healthcare issues worldwide. Posed lifestyle
changes are associated with drastically increased risk of chronic illness and diseases …
changes are associated with drastically increased risk of chronic illness and diseases …
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute …
Objectives. This 2013 update of the practice guidelines for the biological treatment of
unipolar depressive disorders was developed by an international Task Force of the World …
unipolar depressive disorders was developed by an international Task Force of the World …
Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics
M Schulz, S Iwersen-Bergmann, H Andresen… - Critical care, 2012 - Springer
Introduction In order to assess the significance of drug levels measured in intensive care
medicine, clinical and forensic toxicology, as well as for therapeutic drug monitoring, it is …
medicine, clinical and forensic toxicology, as well as for therapeutic drug monitoring, it is …
Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial
CE Angermann, G Gelbrich, S Störk, H Gunold… - Jama, 2016 - jamanetwork.com
Importance Depression is frequent in patients with heart failure and is associated with
adverse clinical outcomes. Long-term efficacy and safety of selective serotonin reuptake …
adverse clinical outcomes. Long-term efficacy and safety of selective serotonin reuptake …
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants
Polymorphisms in CYP2D6 and CYP2C19 affect the efficacy and safety of tricyclics, with
some drugs being affected by CYP2D6 only, and others by both polymorphic enzymes …
some drugs being affected by CYP2D6 only, and others by both polymorphic enzymes …